image
ZyVersa Therapeutics, Inc. ZVSA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.08
-4.42 %
$ 1.16 M
Market Cap
0.0
P/E
BALANCE SHEET
22.1 M ASSETS
-81.34%
Growth Rates
1Year -81.34%
3Years 218.33%
5Years 0.00%
7Years 0.00%
10Years 0.00%
11 M LIABILITIES
-40.36%
Growth Rates
1Year -40.36%
3Years 6.10%
5Years 0.00%
7Years 0.00%
10Years 0.00%
11.1 M EQUITY
-88.92%
Growth Rates
1Year -88.92%
3Years 48.79%
5Years 0.00%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition ZyVersa Therapeutics, Inc.
image
Current Assets 3.35 M
Cash & Short-Term Investments 3.14 M
Receivables 0
Other Current Assets 215 K
Non-Current Assets 18.8 M
Long-Term Investments 0
PP&E 14.8 K
Other Non-Current Assets 18.7 M
Current Liabilities 10.2 M
Accounts Payable 8.43 M
Short-Term Debt 8.66 K
Other Current Liabilities 1.75 M
Non-Current Liabilities 845 K
Long-Term Debt 0
Other Non-Current Liabilities 845 K

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020
ASSETS
Cash & Cash Equivalents 3.1 5.9 0.3 0.2
Short Term Investments 0 0 0 0
Receivables 0 0 0 0
Inventory 0 0 0 0
Other Current Assets 0.2 0.5 0.5 0.2
Total Current Assets 3.4 6.4 0.8 0.3
PP&E 14.8 K 0.1 27.7 K 38.1 K
Intangible Assets 18.6 100.1 0 0
Goodwill 0 11.9 0 0
Long Term Investments 0 0 0 0
Other Long Term Assets 98.5 K 46.7 K 0.3 0.3
Other Assets 0 0 0 0
Total Assets 22.1 118.5 1.1 0.7
LIABILITIES
Accounts Payable 8.4 6.0 2.0 2.3
Short Term Debt 8.66 K 0.1 9.2 2.1
Other Current Liabilities 1.8 1.9 2.5 3.1
Total Current Liabilities 10.2 8.2 13.6 7.6
Long Term Debt 0 0 0 1.7
Deferred Tax Income 0.8 10.3 0 0
Other Liabilities 0 0 0 0
Total Liabilities 11.0 18.5 13.6 9.2
EQUITY
Common Stock 405 902 242 242
Retained Earnings (103.2) (4.9) (52.9) (44.8)
Other Accumulative Comprehensive Income/Loss 0 0 (0.3) (0.3)
Total Equity 11.1 100.0 (12.5) (8.6)
Total Liabilities and Equity 22.1 118.5 1.1 0.7
SHARES OUTSTANDING
Common Shares Outstanding 97.5 K 0.3 0.5 0.5